Snail and Axin2 expression predict the malignant transformation of oral leukoplakia
- PMID: 28939076
- DOI: 10.1016/j.oraloncology.2017.08.004
Snail and Axin2 expression predict the malignant transformation of oral leukoplakia
Abstract
Objectives: Oral leukoplakia (OL) has a well-documented potential risk of malignant transformation into oral squamous cell carcinoma (OSCC), although biomarker(s) predicting malignant potential are limited in capability. The aim of this cross-sectional and retrospective cohort study was to investigate the predictive role of canonical Wnt genes Axin2 and Snail (SNAI1) expression in the malignant transformation of OL lesions.
Materials and methods: The expression of epithelial-mesenchymal transition (EMT) genes Snail and Axin2, which are regulated by the canonical Wnt pathway, were determined using immunohistochemical staining in an OL cohort consisting of 154 samples of patients with long-term follow-up and then evaluated as risk factors for malignant transformation of OL.
Results: Increased Axin2 and Snail abundance were found in 107 (69.5%) and 58 (37.7%) of OL patients, respectively. In a multivariate analysis using gender, age, lesion site, Axin2, and Snail as cofactors, both Axin2 and Snail were independent risk factors for malignant transformation with a hazard ratio of 7.47 (95% confidence interval, 2.23-25.02; P=0.001) and 4.41 (95% confidence interval, 1.78-10.93; P=0.001), respectively. A nomogram for predicting 5-, 10-, and 15-year cancer-free survival probability was developed in patients with OL by including gender, age, lesion site, Axin2, and Snail expression with ac-index of 0.760.
Conclusion: The increased abundance of Snail and Axin2 is highly correlated to malignant transformation of OL, making them novel biomarker(s) predicting oral cancer development.
Keywords: Axin2; Malignant transformation; Nomogram; Oral leukoplakia; Risk prediction; Snail.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.Oral Oncol. 2017 Sep;72:132-139. doi: 10.1016/j.oraloncology.2017.07.015. Epub 2017 Jul 20. Oral Oncol. 2017. PMID: 28797449
-
Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.J Oral Pathol Med. 2019 Jul;48(6):491-498. doi: 10.1111/jop.12862. Epub 2019 May 15. J Oral Pathol Med. 2019. PMID: 30980769
-
Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.Int J Biochem Cell Biol. 2018 Nov;104:34-42. doi: 10.1016/j.biocel.2018.08.016. Epub 2018 Aug 30. Int J Biochem Cell Biol. 2018. PMID: 30172723
-
Hospital-based epidemiological and clinical characterisation of the malignant transformation of oral leukoplakia in a Chinese population.Int Dent J. 2017 Aug;67(4):252-259. doi: 10.1111/idj.12292. Epub 2017 Mar 9. Int Dent J. 2017. PMID: 28276054 Free PMC article. Review. English.
-
Potential noninvasive biomarkers for the malignant transformation of oral leukoplakia: A systematic review and meta-analysis.Cancer Med. 2023 Jul;12(13):14718-14730. doi: 10.1002/cam4.6095. Epub 2023 May 18. Cancer Med. 2023. PMID: 37199052 Free PMC article.
Cited by
-
On the Cutting Edge of Oral Cancer Prevention: Finding Risk-Predictive Markers in Precancerous Lesions by Longitudinal Studies.Cells. 2022 Mar 18;11(6):1033. doi: 10.3390/cells11061033. Cells. 2022. PMID: 35326482 Free PMC article. Review.
-
The mechanism of low molecular weight fucoidan-incorporated nanofiber scaffolds inhibiting oral leukoplakia via SR-A/Wnt signal axis.Front Pharmacol. 2024 Jul 22;15:1397761. doi: 10.3389/fphar.2024.1397761. eCollection 2024. Front Pharmacol. 2024. PMID: 39104391 Free PMC article.
-
The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma.BMC Cancer. 2020 Oct 12;20(1):987. doi: 10.1186/s12885-020-07495-9. BMC Cancer. 2020. PMID: 33046030 Free PMC article.
-
Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside.J Zhejiang Univ Sci B. 2023 May 13;24(10):868-882. doi: 10.1631/jzus.B2200589. J Zhejiang Univ Sci B. 2023. PMID: 37752089 Free PMC article. Review.
-
Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt-Axin2-Snail Cascade.Cancers (Basel). 2021 Sep 15;13(18):4630. doi: 10.3390/cancers13184630. Cancers (Basel). 2021. PMID: 34572856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials